Protein Kinase C Theta Type (nPKC Theta or PRKCQ or EC 2.7.11.13) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Mar 2022	31	Global Markets Direct	ASDR-599144

Published: Mar 2022 - Pages : 31 - Publisher : Global Markets Direct - Report code : ASDR-599144

Astellas Pharma Inc
Bristol-Myers Squibb Co
EpiAxis Therapeutics Pty Ltd
Evommune Inc
HotSpot Therapeutics Inc